How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code DKZ: Enzyme Immunoassay, Amphetamine. View classification details, related manufacturers, 510(k) clearances, and recall records.
225 clearance records and 24 recall records in the covered releases, across 93 source company names and 1 product codes. Dated history runs from Aug 3, 1976 to Oct 30, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| DKZ · Enzyme Immunoassay, Amphetamine | 225 | 24 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ADX AMPHETAMINE/METHAMPHEAMINEK890692 · DKZ | Abbott Laboratories | 510(k) | Aug 25, 1989FDA decision date |
| ABUSCREEN RADIOIMMUNOASSAY FOR METHAMPHETAMINEK894465 · DKZ | Roche Diagnostic Systems, Inc. | 510(k) | Aug 15, 1989FDA decision date |
| EMIT D.A.U. MONOCLONAL AMPHETAMINE/METHAMPHETAMINEK894404 · DKZ | Syva Co. | 510(k) | Aug 11, 1989FDA decision date |
| ABUSCREEN FP FOR AMPHETAMINEK890886 · DKZ | Roche Diagnostic Systems, Inc. | 510(k) | Mar 10, 1989FDA decision date |
| TDX AMPHETAMINE/METHAMPHETAMINE IIK883707 · DKZ | Abbott Laboratories | 510(k) | Oct 20, 1988FDA decision date |
| EMIT D.A.U. MONOCLONAL AMPHETAMINE/METHAMPHETAMINEK884022 · DKZ | Syva Co. | 510(k) | Oct 11, 1988FDA decision date |
| EMIT HVA AMPHETAMINE ASSAYK882589 · DKZ | Syva Co. | 510(k) | Aug 2, 1988FDA decision date |
| TDX (R) AMPHETAMINE CLASSK874770 · DKZ | Abbott Laboratories | 510(k) | Apr 21, 1988FDA decision date |
| REVISED LABELING FOR ADX AMPHETAMINE/METHAMPHETA.K880013 · DKZ | Abbott Laboratories | 510(k) | Mar 1, 1988FDA decision date |
| ABUSCREEN(R) EIA AMPHETAMINEK874836 · DKZ | Roche Diagnostic Systems, Inc. | 510(k) | Feb 16, 1988FDA decision date |
| REVISED LABELING FOR TDX AMPHETAMINE/METHAMPHETA.K874486 · DKZ | Abbott Laboratories | 510(k) | Nov 23, 1987FDA decision date |
| REVISED LABELING FOR AMPHETAMINE TEST KITK874273 · DKZ | Roche Diagnostic Systems, Inc. | 510(k) | Nov 13, 1987FDA decision date |
| REVISED LABELING FOR AMPHETAMINE TEST KITK874274 · DKZ | Roche Diagnostic Systems, Inc. | 510(k) | Nov 13, 1987FDA decision date |
| REVISED LABELING FOR SYVA AMPHETAMINE ASSAYK874080 · DKZ | Syva Co. | 510(k) | Oct 29, 1987FDA decision date |
| LABELING CHANGE AMPHETAMINE DOUBLE ANTIBODYK873755 · DKZ | Diagnostic Products Corp. | 510(k) | Oct 15, 1987FDA decision date |
| ACA DU PONT URINE AMPHETAMINES (U AMP) SCREEN METHK873622 · DKZ | E.I. Dupont DE Nemours & Co., Inc. | 510(k) | Oct 2, 1987FDA decision date |
| DOUBLE ANTIBODY AMPHETAMINE KAPD1 AND KAPD5K871696 · DKZ | Diagnostic Products Corp. | 510(k) | Jun 5, 1987FDA decision date |
| TDX AMPHETAMINE METHAMPHETAMINEK853879 · DKZ | Abbott Laboratories | 510(k) | Oct 28, 1985FDA decision date |
| EMIT D.A.U. AMPHETAMINE ASSAYK842674 · DKZ | Syva Co. | 510(k) | Sep 26, 1984FDA decision date |
| EMIT 700 AMPHETAMINE ASSAY NEW PRODUCTK843458 · DKZ | Syva Co. | 510(k) | Sep 20, 1984FDA decision date |
| MODIF. OF EMIT URINE AMPHETAMINEK833579 · DKZ | Syva Co. | 510(k) | Jan 26, 1984FDA decision date |
| EMIT-STM AMPHETAMINE ASSAYK802623 · DKZ | Syva Co. | 510(k) | Nov 12, 1980FDA decision date |
| EMIT AMPHETAMINE CONFIRMATION REAGENTK760936 · DKZ | Syva Co. | 510(k) | Nov 19, 1976FDA decision date |
| ASSAY, AMPHET. NDC#11711-0127-1 COULTERK760196 · DKZ | Coulter Electronics, Inc. | 510(k) | Aug 3, 1976FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.